Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|November 28, 2017
Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative ColitisXiaohui Wei, Leonid Gibiansky, Yehong Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 6, 2022
Population pharmacokinetic analysis for tisotumab vedotin in patients with locally advanced and/or metastatic solid tumorsLeonid Gibiansky, Chaitali Passey, Jenna Voellinger, et al.
British Journal of Pharmacology|January 22, 2011
Inhaled innate immune ligands to prevent pneumoniaScott E Evans, Michael J Tuvim, Cory J Fox, et al.
The AAPS Journal|January 11, 2017
An Integrated Assessment of the Effects of Immunogenicity on the Pharmacokinetics, Safety, and Efficacy of ElotuzumabChaitali Passey, Johanna Mora, Robert Dodge, et al.
Clinical and Translational Science|June 29, 2022
Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitisCandice Jamois, Leonid Gibiansky, Clarisse Chavanne, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 31, 2015
Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairmentLeonid Gibiansky, Mylène Giraudon, Craig R Rayner, et al.
Clinical Pharmacology and Therapeutics|January 21, 2020
Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and InfantsLeonid Gibiansky, Patanjali Ravva, Neil J Parrott, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2015
Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approachMohamed A Kamal, Kayla Yi Ting Lien, Richard Robson, et al.
Computer Methods and Programs in Biomedicine|October 3, 2012
Facilitating pharmacometric workflow with the metrumrg package for RTimothy T Bergsma, William Knebel, Jeannine Fisher, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2023
Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumorsChaitali Passey, Jenna Voellinger, Leonid Gibiansky, et al.
Pageof 6